NDUFA6
protein-codingNADH:ubiquinone oxidoreductase subunit A6, the group of NADH:ubiquinone oxidoreductase supernumerary subunits|LYR motif containing
Gene summary
This gene encodes a member of the LYR family of proteins that contain a highly conserved tripeptide (LYR) motif near the N-terminus. The encoded protein is an accessory subunit of NADH: ubiquinone oxidorerductase (Complex I), which is the largest enzyme of the mitochondrial membrane respiratory chain. Complex I functions in electron transfer from NADH to the respiratory chain. [provided by RefSeq, Oct 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032636
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032636
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *NDUFA6* and *NDUFA6*-related primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of April 29, 2024. The *NDUFA6* gene encodes the NADH:ubiquinone oxidoreductase (complex I) subunit A6, a complex I accessory protein required for complex I assembly and function within the mitochondria. Defects of this protein lead to complex I deficiency. The first and only report of *NDUFA6* in relation to autosomal recessive primary mitochondrial disease was in 2018 (PMID: 30245030). *NDUFA6* has been associated with a single disease entity to date; mitochondrial complex I deficiency, nuclear type 33 [OMIM# 618253]. This is one disease entity according to the ClinGen Lumping and Splitting Framework, and has been renamed as *NDUFA6*-related primary mitochondrial disease. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included six unique variants (one missense variant, one start loss variant, three frameshift variants, and one nonsense variant predicted to escape nonsense mediated decay) identified in four unrelated cases from one publication (PMIDs: 30245030). Age of onset ranges from the prenatal period to early childhood. Clinical features in affected individuals include small for gestational age, intrauterine growth restriction, oligohydramnios, developmental regression, seizures, dystonia, spasticity, feeding difficulty, optic atrophy, lactic acidosis, and hypoglycemia. White matter abnormalities and/or basal ganglia lesions have been seen on brain imaging. The mechanism of disease is loss of function. This gene-disease relationship is also supported by a biochemical function shared with other genes associated with primary mitochondrial disease (PMID: 33340416), NDUFA6 knock out in HEK293T cells (PMID: 27626371), and a *C.elegans* model (PMID: 38215760). In summary, there is moderate evidence to support the relationship between *NDUFA6* and autosomal recessive *NDUFA6*-related primary mitochondrial disease. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on April 29, 2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0100133
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0032636
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032636
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Medical treatment (eg, riboflavin, uniquinol) may be beneficial; Individuals may have cardiac involvement
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NDUFA6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002490.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 13 | 16 | |||
| missense | 1 | 34 | 3 | 38 | ||
| nonsense | 1 | 1 | 2 | |||
| start loss | 2 | 2 | ||||
| frameshift | 2 | 4 | 1 | 7 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 4 | 4 | 42 | 16 | 0 | 66 |
Highest pathogenic variant AF is 0.00008053914
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002481.3 | 3 | MANE Select | |
| Ensembl | ENSP00000418842.3 | 3 | MANE Select | |
| Ensembl | ENSP00000473478.1 | 2 | Standard | |
| Ensembl | ENSP00000482543.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Retrograde endocannabinoid signaling - Homo sapiens (human)
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
- Alzheimer,s disease - Homo sapiens (human)
- Huntington,s disease - Homo sapiens (human)
- Thermogenesis - Homo sapiens (human)
Biological Process
- mitochondrial electron transport, NADH to ubiquinone
- response to oxidative stress
- mitochondrial respiratory chain complex I assembly
Molecular Function
- NADH dehydrogenase (ubiquinone) activity
Cellular Component
- mitochondrial inner membrane
- mitochondrial respiratory chain complex I
- mitochondrial membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000498737
- Coding exons
- 3
- Length
- 5431
- Individuals with no LoFs
- 125688
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 60
- Defined
- 125748
- p
- 0.000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.799 | 111 | 89.7 | 1.24 | 0.00000513 | 1016 |
| Missense (PolyPhen) | 30 | 28.806 | 1.0415 | 324 | ||
| Synonymous | -2.70 | 53 | 33.2 | 1.60 | 0.00000176 | 301 |
| Loss of Function | 0.168 | 6 | 6.46 | 0.929 | 3.66e-7 | 67 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00032 | 0.00032 | rare |
| South Asian | 0.00029 | 0.00029 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.;
Recessive Scores
- pRec
- 0.336
Intolerance Scores
- LoFtool
- 0.825
- RVIS EVS
- 0.46
- RVIS percentile EVS
- 78.28
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.942
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |